Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can low DHEA-S cause lower testosterone in women when SHBG is not elevated?

Low DHEA-S depletes the precursor pool for peripheral conversion and leads to lower testosterone levels in women when SHBG is not elevated.

SupportedJune 19, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

DHEA-S is an adrenal-derived androgen precursor that can be converted into testosterone and estrogens in peripheral tissues, so low DHEA-S can contribute to lower testosterone in women when SHBG is not elevated.

laying out figure…
All 7 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes adrenal-derived DHEA-S as the main circulating reservoir that peripheral intracrine enzymes convert into testosterone, so reduced DHEA-S limits substrate for androgen production. When SHBG is not elevated, low total testosterone more likely reflects reduced production from depleted precursors rather than increased protein binding, implicating low DHEA-S as a primary driver of low androgen status.

Verified conclusion

Dehydroepiandrosterone sulfate (DHEA-S) serves as the primary reservoir for sex steroid synthesis in women, particularly as direct ovarian production fluctuates with age. Synthesized in the adrenal glands, DHEA-S acts as a stable precursor that peripheral tissues utilize to maintain local hormonal balance.

Mechanistic pathways

  • Intracrine conversion: Peripheral tissues, including the skin, adipose tissue, and liver, possess the enzymatic machinery required to convert DHEA-S into active androgens. The process begins with the hydrolysis of DHEA-S into DHEA by steroid sulfatase (STS). DHEA is then converted to androstenedione by 3β-hydroxysteroid dehydrogenase (3β-HSD) and subsequently into testosterone via 17β-hydroxysteroid dehydrogenase (17β-HSD).
  • Adrenal contribution: In women, approximately 50% of total circulating testosterone is derived from the peripheral conversion of adrenal precursors like DHEA-S. Consequently, a depletion in the DHEA-S pool—often due to aging, adrenal insufficiency, or zona reticularis atrophy—directly limits the substrate available for testosterone biosynthesis.

Role of SHBG and clinical implications

  • Bioavailability and binding: Sex Hormone-Binding Globulin (SHBG) is the primary transport protein for testosterone. High levels of SHBG sequester free testosterone, which can mask the true androgenic status by lowering the "free" bioactive fraction even if total production is stable.
  • Production vs. sequestration: When SHBG is not elevated, total testosterone levels serve as a more reliable proxy for actual hormone production. In this state, a finding of low testosterone is more likely attributable to a production deficit—such as low DHEA-S precursor availability—rather than excessive protein binding. This confirms that low adrenal androgen output is a primary driver of the patient's low androgen status.

Bottom line

The claim is supported by high-confidence evidence. Low DHEA-S directly contributes to reduced testosterone levels in women because it depletes the precursor pool necessary for peripheral conversion. When SHBG is not elevated, this deficit in production is the most significant factor in low systemic testosterone.

References

  1. PAPSS2 Deficiency Causes Androgen Excess via Impaired DHEA Sulfation—In Vitro and in Vivo Studies in a Family Harboring Two Novel PAPSS2 Mutations — academic.oup.com ↗
  2. Analysis of estrogens and androgens in postmenopausal serum and plasma by liquid chromatography–mass spectrometry — pmc.ncbi.nlm.nih.gov ↗
  3. Intracrine Formation of Steroid Hormones in Breast Cancer, Epidermal Keratinocyte, Dermal Fibroblast, and Adipocyte Cell Lines Measured by LC-MS/MS — pmc.ncbi.nlm.nih.gov ↗
  4. Female adipocyte androgen synthesis and the effects of insulin — pmc.ncbi.nlm.nih.gov ↗
  5. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women — pmc.ncbi.nlm.nih.gov ↗
  6. 11-Oxygenated C19 Steroids Do Not Decline With Age in Women. — pmc.ncbi.nlm.nih.gov ↗
  7. SAT-466 Late Diagnosis Of Nonclassical Congenital Adrenal Hyperplasia In A Female With Infertility: A Case Report — academic.oup.com ↗
  8. Sex steroids and sex steroid‐binding globulin levels amongst middle‐aged and elderly men and women from general population — pmc.ncbi.nlm.nih.gov ↗
  9. Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. — pmc.ncbi.nlm.nih.gov ↗
  10. Androgen Status in Healthy Premenopausal Women with Loss of Libido — tandfonline.com ↗
  11. The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases — pmc.ncbi.nlm.nih.gov ↗
  12. Steroid sulfatase and sulfotransferases in the estrogen and androgen action of gynecological cancers: current status and perspectives — pmc.ncbi.nlm.nih.gov ↗
  13. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH) — semanticscholar.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→